Health (PRISME)

  • Presentation
  • Activities
  • Members
  • Publications

The PRISME team is composed of physicists, biochemists, biologists and radiotherapists. We specialize in multidisciplinary research aimed at developing, optimizing and controlling innovative radiotherapies, whether it be hadrontherapy or therapies using radioactive ion-emitting elements or nanoparticles. These radiotherapies aim to improve the treatment of certain cancers by increasing the effect of ionizing radiation in the tumor while minimizing its harmful effects on healthy tissues.

Our multidisciplinary approach aims to quantify, understand and predict the effect of ionizing radiation on living organisms from processes induced at extremely short times (attosecond) at small scales (atomic nucleus) to long-term consequences (years) at the patient level.
We therefore design and carry out irradiation experiments on targets ranging from molecules or cells to small animals and patient samples (tumor, blood). These experiments feed an important part of our activity which consists in modeling the effects of radiation on living organisms.

One of the innovative techniques of radiotherapy is hadrontherapy, which is to send
an ion beam on the tumors to destroy them. We are working, in particular using simulations, data processing and predictions, to improve these systems by having on-line control over irradiation using dedicated detectors. These tools also have applications in imaging.

The activities can be divided into three research areas:

Axis 1 aims to develop simulations and detectors to control patient irradiation by detecting the particles emitted during hadrontherapy treatment. These developments also offer application prospects in the field of diagnostic imaging.

Axis 2 focuses on the development of multi-scale models and simulations to describe and predict the physical, chemical and biological processes induced by irradiation. It also develops irradiation and dosimetric control means for the measurement of radiobiological effects.

Axis 3 quantifies by experiment the effects induced by irradiation with molecular, cellular, multicellular, in-vitro or in-vivo systems. It focuses on the specificities of innovative radiotherapies and the personalization of care.

PERMANENTS:

NON-PERMANENTS:

- DOCTORANTS / DOCTORAL STUDENTS:

- CHERCHEURS NON-PERMANENTS / NON-PERMANENT RESEARCHERS:
546 documents

  • S. Ferrandon, P. Saultier, P. Battiston-Montagne, M. Beuve, C. Rodriguez-Lafrasse, et al.. Telomeric and radioresistance status of glioblastomas: a predictive marker for referrals to hadrontherapy. Bulletin du Cancer, 2011, 98, pp.S102. ⟨in2p3-00842383⟩
  • M. Beuve, L. Chollier, D. Dali, D. Dauvergne, Gerard Montarou, et al.. Evaluation of the biophysical Local Effect Model used in hadrontherapy for the treatment planning. Bulletin du Cancer, 2011, 98, pp.S103-S104. ⟨in2p3-00702733⟩
  • M. Beuve, E. Testa. Hadronthérapie : vers une dosimétrie clinique. Journées de réflexion CNRS/IN2P3 des applications sociétales de la physique nucléaire : énergie et santé, Dec 2010, Saint-François, France. ⟨in2p3-00777491⟩
  • A. Boivin, M. Hanot, M. Maalouf, G. Alphonse, C. Malesys, et al.. Implication of cellular redox buffering in HNSCC tumor escape after X-ray or Carbon ion therapy. 13th Workshop of Ion Beam in Biology and Medecine, Oct 2010, Berkeley, United States. ⟨in2p3-00777783⟩
  • Mauro Testa. Charged particle therapy, ion range verification, prompt radiation. Other [cond-mat.other]. Université Claude Bernard - Lyon I, 2010. English. ⟨NNT : 2010LYO10189⟩. ⟨tel-00566188⟩
  • Fabrice Le Foulher. Simulations Monte Carlo et mesures de l'émission de gamma prompts appliquées au contrôle en ligne en hadronthérapie. Physique Nucléaire Théorique [nucl-th]. Université Claude Bernard - Lyon I, 2010. Français. ⟨NNT : ⟩. ⟨tel-00573263⟩
  • C. Ray, M. Gouanère, D. Dauvergne, M. Bajard, R. Chehab, et al.. RICCE: Research of Internal Clock by Channeling of Electrons. Preliminary results at the LNF-BTF. 4th International Conference on Charged and Neutral Particles Channeling Phenomena "Channeling 2010", Oct 2010, Ferrara, Italy. ⟨in2p3-00777480⟩
  • S. Ferrandon, P. Saultier, P. Battiston-Montagne, C. Malesys, M. Beuve, et al.. Determination of the telomeric status as a radiotherapy response predictive in Glioma. 4th Berder Meeting Biology of ionizing radiation, Sep 2010, Berder, France. ⟨in2p3-00777770⟩
  • Nabil Zahra. Mesure de la dose physique par lms radiochromiques et simulation Monte Carlo pour l'hadronthérapie. Autre [cond-mat.other]. Université Claude Bernard - Lyon I, 2010. Français. ⟨NNT : 2010LYO10088⟩. ⟨tel-00520876v2⟩
  • C. Ray, M. Bajard, J. Constanzo, M. Chevallier, D. Dauvergne, et al.. Dose monitoring in ion therapy by means of prompt radiation. 49th Annual Meeting of the Particle Therapy Co-Operative Group (PTCOG 49), May 2010, Tokyo, Japan. ⟨in2p3-00777466⟩

Powered by HAL logo